These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 20957995)
1. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats. Pang Z; Feng L; Hua R; Chen J; Gao H; Pan S; Jiang X; Zhang P Mol Pharm; 2010 Dec; 7(6):1995-2005. PubMed ID: 20957995 [TBL] [Abstract][Full Text] [Related]
2. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin. Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923 [TBL] [Abstract][Full Text] [Related]
3. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas. Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939 [TBL] [Abstract][Full Text] [Related]
4. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677 [TBL] [Abstract][Full Text] [Related]
5. A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment. Yin Y; Fu C; Li M; Li X; Wang M; He L; Zhang LM; Peng Y Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():159-169. PubMed ID: 27287110 [TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Li X; Ding L; Xu Y; Wang Y; Ping Q Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296 [TBL] [Abstract][Full Text] [Related]
7. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361 [TBL] [Abstract][Full Text] [Related]
8. Synergistic anticancer effects of tetrandrine combined with doxorubicin or vincristine in vitro. Sun AX; Ye ZG; Li CY; Xue BY; Li LF; Cao XF; Yang Q; Dai BQ Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):69-73. PubMed ID: 10437129 [TBL] [Abstract][Full Text] [Related]
9. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease. Hu K; Shi Y; Jiang W; Han J; Huang S; Jiang X Int J Pharm; 2011 Aug; 415(1-2):273-83. PubMed ID: 21651967 [TBL] [Abstract][Full Text] [Related]
10. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379 [TBL] [Abstract][Full Text] [Related]
11. Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma. Zhang M; Asghar S; Tian C; Hu Z; Ping Q; Chen Z; Shao F; Xiao Y Carbohydr Polym; 2021 Feb; 253():117194. PubMed ID: 33278970 [TBL] [Abstract][Full Text] [Related]
12. Angiopep-2-conjugated poly(ethylene glycol)- Lu F; Pang Z; Zhao J; Jin K; Li H; Pang Q; Zhang L; Pang Z Int J Nanomedicine; 2017; 12():2117-2127. PubMed ID: 28356732 [TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798 [TBL] [Abstract][Full Text] [Related]
14. Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes. Pang Z; Gao H; Yu Y; Chen J; Guo L; Ren J; Wen Z; Su J; Jiang X Int J Pharm; 2011 Aug; 415(1-2):284-92. PubMed ID: 21651966 [TBL] [Abstract][Full Text] [Related]
15. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes. Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650 [TBL] [Abstract][Full Text] [Related]
16. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery. Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038 [TBL] [Abstract][Full Text] [Related]
17. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115 [TBL] [Abstract][Full Text] [Related]
18. Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells. He QY; Meng FH; Zhang HQ Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):179-81. PubMed ID: 9772674 [TBL] [Abstract][Full Text] [Related]
19. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Lin R; Shi Ng L; Wang CH Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377 [TBL] [Abstract][Full Text] [Related]
20. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. Pang Z; Lu W; Gao H; Hu K; Chen J; Zhang C; Gao X; Jiang X; Zhu C J Control Release; 2008 Jun; 128(2):120-7. PubMed ID: 18436327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]